4imprint Group PLC
02 November 2007
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
4imprint Group PLC
2. Reason for the notification (yes/no):
An acquisition or disposal of voting rights: (Yes)
An acquisition or disposal of financial instruments which may result
in the acquisition of shares already issued to which voting rights are
attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
3. Full name of person(s) subject to the notification obligation (iii):
Aberforth Partners LLP
4. Full name of shareholder(s) (if different from 3.) (iv):
Share holder Shares
1. Aberforth Smaller Companies Trust plc 1,848,300
2. Aberforth UK Small Companies Fund 1,628,600
3. The Church Commissioners for England 315,900
4. Aberforth Geared Capital & Income Trust plc 264,600
1,2,4 = registered in the name of Nortrust Nominees Ltd A/c Aberfth, 3 =
The Church Commissioners for England (Chase GIS) Nominees Ltd
5. Date of the transaction and date on which the threshold is crossed or reached
if different) (v):
01/11/2007
6. Date on which issuer notified:
02/11/2007
7. Threshold(s) that is/are crossed or reached:
15%
8. Notified details:
N/A
A: Voting rights attached to shares
Class/type of shares Situation previous to Resulting situation after the triggering transaction (vii)
the Triggering
If possible using the transaction (vi)
ISIN CODE
Number of Number of Number of Number of voting % of voting rights
shares voting rights Shares rights (ix)
(vii)
Direct (x) Indirect (xi) Direct Indirect
ordinary shares 3,338,700 3,338,700 4,057,400 N/A 4,057,400 N/A 15.98
GB0006640972
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial (xiii) Period/ Date (xiv) rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights % of voting rights
4,057,400 15.98
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
Held by Aberforth Partners LLP
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
In addition, Aberforth LLP is interested in a further 679,600 shares although
we do not have access to the voting rights of theses shares. Aberforth Partners
LLP is, therefore interested on a total of 4,737,000 shares of the above
Company. This interest arises as a result of the discretionary investment
management powers that we can exercise over the funds of our client. Aberforth
Partners LLP is not the beneficial owner of these shares.
14. Contact name:
David Holland, Aberforth Partners LLP
15. Contact telephone number:
0131-220-0733
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.